MedTrace Logo

Evolution of Diaphragm Thickness Under Veno-arterial ECMO

NCT04052230 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-05-12

No results posted yet for this study

Summary

The main objective is to evaluate the evolution of the thickness of the diaphragm (during the first week of treatment) by VA ECMO in the resuscitation patients.

The comprehension of the mechanisms involved in the diaphragm ailment will identify modifiable factors that lead to muscle degradation and thus to the deterioration of patients' prognosis.

Conditions

  • Diaphragm
  • Extracorporeal Membrane Oxygenation Complication

Interventions

OTHER

ultrasound measure

Admission to the intensive care unit, and setting up an ECMO Daily monitoring from D1 to D7, follow up at D60

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-13
Primary Completion
2022-02-18
Completion
2022-04-19

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04052230 on ClinicalTrials.gov